Cohort study2022Open access

Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States

Wang K, Qian D, Hu Y, Cheng Y, Ge S, Yao Y

American journal of nephrology · 15 citations

Review labels

No stated lifestyle adjustment

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Cohort study (indexed by PubMed)
Studied in
People
Main outcome
Clinical events such as disease or death
Intake measured by
Not stated

Who paid for it

Funding
Independent funding

Based on full-text disclosure statement.

Publication

Published
2022-01-01 · Am J Nephrol · vol. 53 · issue 6 · pp. 503–512
Publisher
Karger Publishers
Cited
17 citations · more than 80% of similar papers · 1.5× the field average
References
55 works
Access
Open access (hybrid journal) · CC-BY-NC
Research areas
Nuts composition and effects · Botany, Ecology, and Taxonomy Studies · Oral Health Pathology and Treatment
Keywords
Medicine, Kidney disease, Hazard ratio, Confidence interval, Proportional hazards model, Population, Logistic regression, Internal medicine, Nut, Demography, Environmental health
MeSH
humans, nuts, cardiovascular diseases, diet, nutrition surveys, risk factors, prospective studies, adult, united states, renal insufficiency, chronic

6 authors

From CN

  • Koushu WangTongji Hospital; Huazhong University of Science and Technology
  • Duo QianTongji Hospital; Huazhong University of Science and Technology
  • Yuncan HuTongji Hospital; Huazhong University of Science and Technology
  • Yichun ChengTongji Hospital; Huazhong University of Science and Technology
  • Shuwang GeTongji Hospital; Huazhong University of Science and Technology
  • Ying YaoTongji Hospital; Huazhong University of Science and Technology

Abstract

Background

Nuts have been found to have beneficial effects on some diseases, including cardiovascular disease and cancer, in several studies. However, there are few studies to show the effects of nuts on chronic kidney disease (CKD). Thus, we conducted this study to examine the association between the consumption frequency of nuts and the prevalence and mortality of CKD among adults in the USA.

Methods

We analyzed data from 6,072 individuals (aged ≥20 years) who participated in the NHANES 2003-2006 following the scheduled procedure. Data on death were provided by the CDC. A logistic regression model was used to evaluate the association between nut consumption frequency and the prevalence of CKD. A Cox proportional hazards regression model was performed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between nut consumption frequency and all-cause mortality and cardiovascular mortality in the CKD and non-CKD populations.

Results

Consuming nuts 1-6 times per week was associated with a lower prevalence of CKD (model 3: OR: 0.67; 95% CI: 0.49-0.91). In addition, higher nut consumption was significantly associated with lower all-cause and cardiovascular mortality in the non-CKD population. For the CKD population, a consistently significant inverse association could be seen between consuming nuts 1-6 per week and all-cause mortality (model 3: HR: 0.63; 95% CI: 0.47-0.86). No groups showed a significant difference in cardiovascular mortality compared with the reference in the full model.

Conclusion

We recommend the CKD population to have an adequate intake of nuts 1-6 times per week, while the consumption frequency can be more flexible for the non-CKD. Further prospective studies should be conducted to confirm this conclusion.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.